Currently Viewing:
Newsroom
Currently Reading
Blood Clots in MPN Related to Higher Cost, Length of Stay for Patients With MPN
August 17, 2019 – AJMC Staff
FDA Panel Backs Use of Descovy for HIV Prevention in Men, Transgender Women
August 16, 2019 – Jaime Rosenberg
Researcher Excited About Future of Psoriasis Treatment
August 16, 2019 – Allison Inserro
This Week in Managed Care: August 16, 2019
August 16, 2019
AJMC® in the Press, August 16, 2019
August 16, 2019 – AJMC Staff
Pediatric Leukemia Treatment Linked to Increased Risk of Infections, Study Finds
August 16, 2019 – Alison Rodriguez
5 Findings From the August 2019 Issue of AJMC®
August 16, 2019 – Christina Mattina
Treatment for Parental Tobacco Use Shown to Be Significantly Effective in a Pediatric Setting, Study Shows
August 16, 2019 – Matthew Gavidia
What We're Reading: Generic Pricing Probe; EpiPen Coverage; Mass. Insurers to Merge
August 16, 2019 – AJMC Staff

While PrEP Use Has Skyrocketed Among Urban MSM, Geographic Access Lags Elsewhere

Jaime Rosenberg
As the CDC released data showing an approximate 500% increase in the use of pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in urban areas between 2014 and 2017, a study published in the American Journal of Public Health revealed that a significant amount of MSM elsewhere live in PrEP-access deserts.
As the CDC released data showing an approximate 500% increase in the use of pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in urban areas between 2014 and 20171, a study published in the American Journal of Public Health revealed that a significant amount of MSM elsewhere live in PrEP-access deserts2.

According to CDC data, between 2014 and 2017, PrEP use increased from just 6% to 35% while awareness of the prevention pill increased from 60% to 90% in urban areas. CDC researchers collected data from 20 urban areas, including Atlanta, Georgia; Baltimore, Maryland; Boston, Massachusetts; New York City, New York; Newark, New Jersey; San Francisco, California; and Seattle, Washington. In 2017, more than 80% of MSM in 17 of the urban areas were aware of PrEP.

In 2014 and 2017, a total of 18,610 sexually active MSM were interviewed, 9640 of whom were interviewed in 2014 and 8970 of whom were interviewed in 2017. The researchers narrowed down the cohort to 7873 MSM who had negative HIV test results but were at risk for infection.

“Although PrEP use in MSM in this analysis increased approximately 500% from 2014 to 2017, only approximately one in three men at risk for HIV infection reported using PrEP,” noted the researchers. “Models examining the impact of PrEP use on incidence predict that the use of PrEP by 30%-40% of MSM with PrEP indications in a community could result in approximately one-third of new HIV infections being averted over a 10-year period, with greater predicted impact if coverage is increased.”

In June, the United States Preventive Services Task Force for the first time issued a recommendation for PrEP for HIV prevention, offering the pill a grade A recommendation. As a result, coverage of the pill will increase in the coming years.

While almost all demographics reported increased use of PrEP between 2014 and 2017, some racial disparities remained even after accounting for income, health insurance, and region. For example, in 2017, 26% of blacks reported PrEP use, compared with 42% of whites. During the same year, 30% of Hispanic MSM reported using the pill. However, the difference in PrEP use between Hispanics and whites was no longer significant after controlling for income, health insurance, and region.

“The overall impact and efficiency of PrEP at averting new infections is greater in communities with a prevalence of HIV,” wrote the researchers. “Therefore, efforts focused on increasing PrEP use among black and Hispanic MSM, who have a higher prevalence of HIV infection, might substantially reduce the incidence of HIV infections.”

One of the most significant barriers blocking access to PrEP for MSM living in urban areas, even more so in less-urban areas, is geographic access to the pill, according to the study published in the American Journal of Public Health, which found that 1 in 8 MSM in 2017 lived a 30-minute 1-way drive away from the nearest PrEP provider, and a sizable minority (5%) lived a 60-minute drive away.

“This study of PrEP deserts illustrates that a substantial number of individuals for whom PrEP would be recommended have limited geographic access to care: more than 100,000 would need to travel more than 60 minutes round-trip per PrEP care visit, and more than 38,000 would travel more than 120 minutes.”

The researchers collected data on PrEP providers using PrEP Locator, a national, publicly available database, and identified 844,574 PrEP-eligible MSM from county-level urbanicity classification and population estimates.

PrEP providers were concentrated in urban areas, particularly around major cities. The data also revealed that large areas with the lowest levels of geographic access, reaching travel times of over 90 minutes, were common in low-population areas in the West and Midwest but were also found in more populated areas in the South. While PrEP deserts existed in every geographic area, less-urban areas accounted for the majority of PrEP-eligible populations living in 30-minute (55%) and 60-minute deserts (84%).

According to the researchers, the study findings point to the need for interventions to increase PrEP access, including provider training, alternative venue models, and telemedicine.

References:

1. Finlayson T, Cha S, Xia M, et al. Changes in HIV preexposure prophylaxis awareness and use among men who have sex with men—20 urban areas, 2014 and 2017 [posted online July 12, 2019]. MMWR Morb Mortal Wkly Rep. 2019;68:597–603. doi: 10.15585/mmwr.mm6827a

2. Siegler A, Bratcher A, Weiss K. Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States [published online July 18, 2019]. Am J Public Health. doi: 10.2105/AJPH.2019.30517

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up